Bailard’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,431
Closed -$236K 744
2022
Q3
$236K Buy
+10,431
New +$245K 0.01% 529
2022
Q2
Sell
-15,125
Closed -$369K 735
2022
Q1
$369K Buy
15,125
+1,715
+13% +$42.8K 0.01% 475
2021
Q4
$345K Sell
13,410
-2,800
-17% -$72.5K 0.01% 494
2021
Q3
$424K Hold
16,210
0.01% 432
2021
Q2
$426K Buy
16,210
+5,410
+50% +$141K 0.01% 437
2021
Q1
$279K Buy
10,800
+955
+10% +$25.1K 0.01% 540
2020
Q4
$262K Buy
+9,845
New +$260K 0.01% 473

Other funds holding IBD

Bailard's IBD Position: Q4 2022 in Review

Bailard sold out of Inspire Corporate Bond ETF (IBD) in Q4 2022, closing a stake of 10,431 shares — an estimated $236K sold.

Bailard first reported a position in IBD in Q4 2020 and held it in 7 quarters. The position peaked at $426K in Q2 2021. 51 funds tracked by Wall St. Rank hold IBD as of Q4 2022.

  • Bailard reported no remaining Inspire Corporate Bond ETF position as of Q4 2022 after selling out during the quarter.
  • Bailard sold 10,431 Inspire Corporate Bond ETF shares in Q4 2022, an estimated $236K.
  • Bailard first reported a position in Inspire Corporate Bond ETF in Q4 2020 and held it in 7 quarters.
  • Bailard's Inspire Corporate Bond ETF position peaked at $426K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q4 2022.

Based on Bailard's 13F filing for Q4 2022, filed 2 Feb 2023.